<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Sera Prognostics, Inc. — News on 6ix</title>
<link>https://6ix.com/company/sera-prognostics-inc</link>
<description>Latest news and press releases for Sera Prognostics, Inc. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 22 Apr 2026 12:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/sera-prognostics-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835becf78dffbe2df117cf1.webp</url>
<title>Sera Prognostics, Inc.</title>
<link>https://6ix.com/company/sera-prognostics-inc</link>
</image>
<item>
<title>SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-conference-call-and-webcast-of-first-quarter-fiscal-year-2026-financial-results-on-may-6-2026</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-conference-call-and-webcast-of-first-quarter-fiscal-year-2026-financial-results-on-may-6-2026</guid>
<pubDate>Wed, 22 Apr 2026 12:05:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced it will report first quarter fiscal year 2026 financial results on Wednesday May 6, 2026, after the close of the market. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.m. Eastern Time. A pr</description>
</item>
<item>
<title>SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-reports-fourth-quarter-and-full-year-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-reports-fourth-quarter-and-full-year-2025-financial-results</guid>
<pubDate>Wed, 18 Mar 2026 04:00:00 GMT</pubDate>
<description>SALT LAKE CITY, March 18, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health</description>
</item>
<item>
<title>SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FOURTH QUARTER AND FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 18, 2026</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-conference-call-and-webcast-of-fourth-quarter-and-fiscal-year-2025-financial-results-on-march-18-2026</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-conference-call-and-webcast-of-fourth-quarter-and-fiscal-year-2025-financial-results-on-march-18-2026</guid>
<pubDate>Wed, 04 Mar 2026 13:05:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced it will report fourth quarter and fiscal year 2025 financial results on Wednesday March 18, 2026, after the close of the market. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.m. Eastern Ti</description>
</item>
<item>
<title>SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-present-td-cowen-130500365</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-present-td-cowen-130500365</guid>
<pubDate>Tue, 17 Feb 2026 13:05:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026 at 1:10 p.m. ET. Members of management will participate in a fireside chat, highlighting Sera's latest achievements. The conference, to be held March 2-4, 2026, in Boston, will also inc</description>
</item>
<item>
<title>Landmark Study Finds PreTRM® Blood Test Reduces Earliest Preterm Births and Newborn Complications</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/landmark-study-finds-pretrm-blood-133000553</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/landmark-study-finds-pretrm-blood-133000553</guid>
<pubDate>Wed, 07 Jan 2026 13:30:00 GMT</pubDate>
<description>A randomized controlled trial of 5,018 women has found that a simple blood test, when paired with targeted interventions, can significantly reduce the risk of preterm birth and improve outcomes for newborns. The findings, published in PREGNANCY, the peer-reviewed journal of the Society for Maternal-Fetal Medicine, highlight the effectiveness of the PreTRM Test in identifying women at higher risk for spontaneous preterm birth and guiding preventive care.</description>
</item>
<item>
<title>Sera Announces Publication Acceptance for PRIME Study</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-announces-publication-acceptance-prime-130000586</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-announces-publication-acceptance-prime-130000586</guid>
<pubDate>Mon, 24 Nov 2025 13:00:00 GMT</pubDate>
<description>Sera Prognostics, Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the findings of the Prematurity Risk Assessment Combined with Clinical Interventions for Improved Neonatal OutcoMEs (PRIME) study were accepted for publication in a peer-reviewed journal.</description>
</item>
<item>
<title>SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-reports-third-quarter-210500120</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-reports-third-quarter-210500120</guid>
<pubDate>Thu, 13 Nov 2025 21:05:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the third quarter of 2025 ended September 30, 2025.</description>
</item>
<item>
<title>SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2025 FINANCIAL RESULTS ON NOVEMBER 13, 2025</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-conference-call-200500846</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-conference-call-200500846</guid>
<pubDate>Thu, 30 Oct 2025 20:05:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced it will report third quarter fiscal year 2025 financial results on Thursday November 13, 2025, after the close of the market. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.m. Eastern Time.</description>
</item>
<item>
<title>Sera Prognostics Names Dr. Tiffany Inglis Chief Medical Officer</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-names-dr-tiffany-120500566</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-names-dr-tiffany-120500566</guid>
<pubDate>Wed, 01 Oct 2025 12:05:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker testing to help deliver information to doctors and patients, today announced the appointment of Tiffany Inglis, MD, FACOG, as Chief Medical Officer. With extensive clinical leadership expertise, Dr. Inglis will lead Sera's clinical operations to establish the company as a leader in women's health diagnostics to improve the health of pregnant</description>
</item>
<item>
<title>SERA PROGNOSTICS TO PRESENT AT H.C. WAINWRIGHT 27TH ANNUAL GLOBAL INVESTMENT CONFERENCE</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-present-h-c-120500905</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-present-h-c-120500905</guid>
<pubDate>Thu, 28 Aug 2025 12:05:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the H.C. Wainwright 27th Annual Global Investment Conference on Friday, September 5, 2025 at 7:00 a.m. ET. Zhenya Lindgardt, President and CEO, will present a company update, highlighting Sera's latest achievements. The conference, to be held September 8-10,</description>
</item>
<item>
<title>SERA PROGNOSTICS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-reports-second-quarter-200500020</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-reports-second-quarter-200500020</guid>
<pubDate>Wed, 06 Aug 2025 20:05:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the second quarter of 2025 ended June 30, 2025.</description>
</item>
<item>
<title>Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2025 Financial Results on August 6, 2025</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-conference-call-200500642</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-conference-call-200500642</guid>
<pubDate>Tue, 29 Jul 2025 20:05:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will report second quarter fiscal year 2025 financial results on Wednesday, August 6, 2025, after the close of the market. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.m. Eastern</description>
</item>
<item>
<title>SERA PROGNOSTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-participate-upcoming-investor-123000908</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-participate-upcoming-investor-123000908</guid>
<pubDate>Thu, 29 May 2025 12:30:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that members of the Sera team will participate in the following upcoming investor conferences:</description>
</item>
<item>
<title>SERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-present-rbc-global-200500632</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-present-rbc-global-200500632</guid>
<pubDate>Wed, 14 May 2025 20:05:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, from 9:30 – 9:55 a.m. ET. Zhenya Lindgardt, President and CEO, will participate in a fireside chat and provide a company update and discuss the company's latest achievements.</description>
</item>
<item>
<title>SERA PROGNOSTICS APPOINTS LEE ANDERSON AS CHIEF COMMERCIAL OFFICER</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-appoints-lee-anderson-204000287</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-appoints-lee-anderson-204000287</guid>
<pubDate>Thu, 08 May 2025 20:40:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the appointment of Lee Anderson as Chief Commercial Officer. Bringing more than 30 years of cross-functional leadership experience in sales, marketing, customer service, strategic accounts, and training, Mr. Anderson has a proven track record of driving business growth and enhancing sales s</description>
</item>
<item>
<title>SERA PROGNOSTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-reports-first-quarter-200500391</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-reports-first-quarter-200500391</guid>
<pubDate>Wed, 07 May 2025 20:05:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the first quarter of 2025 ended March 31, 2025.</description>
</item>
<item>
<title>Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2025 Financial Results on May 7, 2025</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-conference-call-123000315</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-conference-call-123000315</guid>
<pubDate>Thu, 24 Apr 2025 12:30:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will report first quarter fiscal year 2025 financial results on Wednesday, May 7, 2025, after the close of the market. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.m. Eastern Time</description>
</item>
<item>
<title>SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-appointment-jeff-201000675</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-appointment-jeff-201000675</guid>
<pubDate>Wed, 19 Mar 2025 20:10:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that Jeff Elliott will join its Board of Directors on March 20, 2025. The Company further announced that Ryan Trimble—after 14 years serving Sera, its customers and its shareholders—has informed the Company of his intention to retire and step down as a director effective June 30, 2025 as pa</description>
</item>
<item>
<title>SERA PROGNOSTICS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTS</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-reports-fourth-quarter-200500574</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-reports-fourth-quarter-200500574</guid>
<pubDate>Wed, 19 Mar 2025 20:05:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the fourth quarter and full year ended December 31, 2024.</description>
</item>
<item>
<title>Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2024 Financial Results on March 19, 2025</title>
<link>https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-conference-call-123000981</link>
<guid isPermaLink="true">https://6ix.com/company/sera-prognostics-inc/news/sera-prognostics-announces-conference-call-123000981</guid>
<pubDate>Tue, 11 Mar 2025 12:30:00 GMT</pubDate>
<description>Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that it will report fourth quarter and full year 2024 financial results on Wednesday, March 19, 2025, after the close of the market. The Company will host a corresponding conference call and live webcast to discuss operational highlights, financial results and key topics at 5:00 p.m. Easter</description>
</item>
</channel>
</rss>